Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
GPRC5D VHH recombinant monoclonal antibody
GREM1 VHH recombinant monoclonal antibody
GUCY2C VHH recombinant monoclonal antibody
HAVCR2 VHH recombinant monoclonal antibody
HER2 VHH recombinant monoclonal antibody
HGF VHH recombinant monoclonal antibody
HLA-G VHH recombinant monoclonal antibody
HTRA1 VHH recombinant monoclonal antibody
ICAM1 VHH recombinant monoclonal antibody
ICOS VHH recombinant monoclonal antibody
ICOSLG VHH recombinant monoclonal antibody
IFNA1 VHH recombinant monoclonal antibody